In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Isela Montúfar-RoblesDivisión de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico.
Blanca M Zapotitla-RománSubdirección de Investigación Clínica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
Gilberto Vargas-AlarcónDirección de Investigación, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.ORCID 0000-0001-7916-5163 José Manuel FragosoLaboratorio de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.ORCID 0000-0003-3137-7815 Silvia Jiménez-MoralesLaboratorio de Innovación y Medicina de Precisión Núcleo A, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.ORCID 0000-0002-6590-9712 Jorge Flavio Mendoza-RincónLaboratorio de Oncología Molecular, L9 (UMIEZ), Campus II, FES-Zaragoza-UNAM, Mexico City 09230, Mexico.
Alberto Cedro-TandaNúcleo B de Innovación en Medicina de Precisión, Instituto Nacional de Medicina Genómica, Mexico City 14610, Mexico.ORCID 0000-0001-8708-462X Rosa Elda Barbosa-CobosServicio de Reumatología, Hospital Juárez de México, Mexico City 07760, Mexico.
Gustavo Rojas-VelazcoUnidad de Cuidados Intensivos, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
Julian Ramírez-BelloSubdirección de Investigación Clínica, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
2',5'-Oligoadenylate SynthetaseCOVID-19Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAllelesCase-Control StudiesFemaleGenotypeHaplotypesHumansLinkage DisequilibriumMaleMexicoMiddle AgedSARS-CoV-22',5'-Oligoadenylate SynthetaseOAS1 protein, humanOAS3 protein, humanCOVID-19SARS-CoV-2severitySNVsusceptibility
Identifiers
PMID41977153
PMCPMC13073408
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390